
2023 Pharmacy Benefit Trends and Predictions
2022 is coming to an end, leaving many eager to see what the new year has in store. What can we expect in the pharmacy

2022 is coming to an end, leaving many eager to see what the new year has in store. What can we expect in the pharmacy

Partnerships present a unique opportunity to expand services and drive greater value. The concept of working separately but together is advantageous in the way that

Pharmacy plan designs encompass everything from cost-sharing arrangements to formulary management to utilization review programs. When combined, they create a well-managed pharmacy plan that drives

After several years of debate and various proposals, Congress has passed prescription drug reform. Although the full impact of the bill is not yet understood,

One area of health care rapidly gaining popularity is digital therapeutics (DTx). These are advanced medical devices that deliver software-based interventions to patients to treat,

For most people, the beginning of March means spring cleaning — but have you ever thought of spring cleaning your medicine cabinet? It is important

Patient assistance dollars from pharmaceutical companies have been a growing area in recent years. Assistance dollars have risen exponentially as pharmaceutical companies work to get

There seems to be enthusiasm as we all turn our backs on 2021. Enthusiasm for 2022 is coming with a much more cautious tone. In

In 2020, the world experienced an incredibly fast vaccine approval, with the Pfizer COVID-19 vaccine receiving emergency use authorization from the U.S. Food and Drug

Diabetes Management Diabetes is a complex and progressive medical condition associated with abnormally elevated blood sugar levels. If left untreated or uncontrolled, diabetes may cause

Lowering Costs and Improving Participant Experience In the constantly evolving pharmacy benefit management (PBM) industry, pharmacy expenses and participants’ expectations continue to rise. To keep

In case you missed it, National CooperativeRx produced a webinar educating the audience on biologic drugs and regulatory implications, the current market status of biosimilars and